Running summarizing tools on a new article
Check the paper below, then start its synthesis.
An overview of stem cell-based therapy towards the treatment of Alzheimer’s disease
San‐Chi Chen (University College London)
Abstract: The classic pharmacological approach toward Alzheimer’s disease treatment uses acetylcholinesterase inhibitors (AChEIs), where patients’ behavior and cognitive symptoms can be treated. However, the pharmacological approaches available can only relieve patients’ symptoms to some extent instead of acting as a cure. With the recent advancements in regenerative medicine, extensive pre-clinical studies have been conducted to test if stem cell therapy can be a cure for Alzheimer’s disease. The stem cell type being investigated through the treatment of Alzheimer’s disease includes embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs), and neural stem cells (NSCs). This review briefly introduces the causes and pharmacological approach to Alzheimer’s disease, highlights some of the critical results reported from the pre-clinical studies and discusses the challenges associated with each type of cell when used as a source for conducting stem cell therapy for Alzheimer’s disease. Although preclinical studies have proved relevant mediated effects to Alzheimer’s disease can be induced by stem cell therapy.